Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
38%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
17%
ALSO IN PPH
PPH
27
HOLDINGS
42%
ALSO IN XLV
SECTOR DRIFT (XLV minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.7% | 18.6% | 14.7% |
|
MERCK & CO. INC. | 6.0% | 11.0% | 6.0% |
|
JOHNSON & JOHNSON | 10.7% | 4.5% | 4.5% |
|
ABBVIE INC | 7.3% | 4.5% | 4.5% |
|
PFIZER INC | 2.6% | 5.1% | 2.6% |
XLV Overweight Relative to PPH
|
JOHNSON & JOHNSON | 6.2% |
|
UNITEDHEALTH GROUP INC | 5.8% |
|
AMGEN INC | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.7% |
|
ABBOTT LABORATORIES | 3.1% |
|
GILEAD SCIENCES INC | 3.0% |
|
ABBVIE INC | 2.9% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
|
DANAHER CORP | 2.1% |
|
INTUITIVE SURGICAL INC | 2.1% |
XLV Underweight Relative to PPH
 |
NOVARTIS AG-ADR | -10.4% |
|
MERCK & CO. INC. | -5.0% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.0% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | -4.0% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
ELI LILLY & CO | -3.9% |
|
ASTRAZENECA PLC-SPONS ADR | -3.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -3.2% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.1% |
|
MCKESSON CORP | -3.0% |